DrugPatentWatch Database Preview

Lupin Company Profile

« Back to Dashboard

What is the competitive landscape for LUPIN, and what generic alternatives to LUPIN drugs are available?

LUPIN has one hundred and seventy-six approved drugs.

There are five US patents protecting LUPIN drugs. There are sixteen tentative approvals on LUPIN drugs.

There are eighty-five patent family members on LUPIN drugs in thirty-seven countries and two hundred and forty-two supplementary protection certificates in thirteen countries.

Summary for Lupin

International Patents:	85
US Patents:	5
Tradenames:	141
Ingredients:	122
NDAs:	176
Patent Litigation for Lupin:	See patent lawsuits for Lupin
PTAB Cases with Lupin as petitioner:	See PTAB cases with Lupin as petitioner

Drugs and US Patents for Lupin

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lupin Atlantis	DESOXIMETASONE	desoximetasone	OINTMENT;TOPICAL	208104-001	Dec 1, 2016	AB	RX	No	No
Lupin Ltd	ARMODAFINIL	armodafinil	TABLET;ORAL	200751-004	Nov 28, 2016	AB	RX	No	No
Lupin Ltd	MEMANTINE HYDROCHLORIDE	memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	206028-003	Sep 28, 2016	AB	RX	No	No
Lupin Ltd	LOSARTAN POTASSIUM	losartan potassium	TABLET;ORAL	078232-002	Oct 6, 2010	AB	RX	No	No
Lupin	CEFOTAXIME SODIUM	cefotaxime sodium	INJECTABLE;INJECTION	065124-002	Sep 24, 2003		DISCN	No	No

Expired US Patents for Lupin

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lupin Atlantis	ANTARA (MICRONIZED)	fenofibrate	CAPSULE;ORAL	021695-001	Nov 30, 2004	4,800,079
Lupin Atlantis	ANTARA (MICRONIZED)	fenofibrate	CAPSULE;ORAL	021695-003	Nov 30, 2004	4,800,079
Lupin Atlantis	ANTARA (MICRONIZED)	fenofibrate	CAPSULE;ORAL	021695-002	Nov 30, 2004	4,800,079

Paragraph IV (Patent) Challenges for LUPIN drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Delayed-release Tablets	20 mg		2015-06-03
	for Oral Suspension	500 mg/5 mL		2014-07-22

International Patents for Lupin Drugs

Country	Document Number	Estimated Expiration
South Africa	200200169
Switzerland	707330
China	1360499
Norway	20020014
Ukraine	72925

Supplementary Protection Certificates for Lupin Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C0040	France		PRODUCT NAME: EZETIMIBE; SIMVASTATINE; NAT. REGISTRATION NO/DATE: NL 31849 20050728; FIRST REGISTRATION: DE - 58 878 00 00 20040402
49/2008	Austria		PRODUCT NAME: WIRKSTOFFKOMBINATION VON ETHINYLESTRADIOL UND DROSPIRENON
00099	Netherlands		PRODUCT NAME: BIMATOPROST; NAT. REGISTRATION NO/DATE: EU/1/02/205/001 20020308; FIRST REGISTRATION: EU/1/02/205/001 20020308
C/GB03/034	United Kingdom		PRODUCT NAME: MOXIFLOXACIN AND PHARMACEUTICALLY USABLE HYDRATES AND ACID ADDITION SALTS THEREOF AND THE ALKALI METAL, ALKALINE EARTH METAL, SILVER AND GUANIDINIUM SALTS OF THE UNDERLYING CARBOXYLIC ACIDS AND THE RACEMATES THEREOF; REGISTERED: DE 45263.00.00 19990621; UK PL 000 10/0291 20030313
C/GB97/023	United Kingdom		PRODUCT NAME: DONEPEZIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, INCLUDING THE HYDROCHLORIDE; REGISTERED: UK PL 10555/0006 19970214; UK PL 10555/0007 19970214

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Lupin
• Lupin Atlantis
• Lupin Ltd
• Lupin Pharms